The genetic testing of the tumor revealed a MUTYH gene mutation, which has been classically linked to colorectal and gastrointestinal cancer pathways [3], as well as a mutation in the BARD1 (BRCA1-associated RING domain 1) gene, which is classified as a mutation of unknown clinical significance currently. This evidence concerns the gene BARD1 and neoplasm.